BACKGROUND: Most non-syndromic congenital heart defects (CHD) are caused by a complex interaction between maternal lifestyle factors, environmental exposures, and maternal and fetal genetic variants. Maternal periconceptional intake of folic acid containing vitamin supplements is reported to decrease the risk of CHD. The 677C-->T and 1298A-->C polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene decrease enzyme activity. OBJECTIVE: To examine the relation between CHD and maternal and fetal MTHFR polymorphisms. METHODS: 375 nuclear families were studied. The transmission/disequilibrium test was used to test for transmission distortion in complete triads. A log-linear approach was used to test for associations between CHD and maternal and offspring polymorphisms, and to estimate independently the contributions of maternal and fetal variants to relative risks. Haplotype frequencies were estimated and a haplotype transmission disequilibrium test carried out. RESULTS: The 1298C allele was transmitted less often than expected (p = 0.0013). There was no distortion in the transmission of the 677T allele, neither was there evidence of a parent of origin effect in the transmission of either of the single nucleotide polymorphisms. The 677C-1298C haplotype was also transmitted less often than expected (p = 0.0020). The relative risk associated with inheriting one copy of the 1298C allele was 0.64 (95% confidence interval, 0.48 to 0.87) and the that associated with inheriting two copies of the 1298C allele, 0.38 (0.21 to 0.70). CONCLUSIONS: The apparent protective effect of the MTHFR 1298C allele against CHD could have several explanations and further study is needed.
BACKGROUND: Most non-syndromic congenital heart defects (CHD) are caused by a complex interaction between maternal lifestyle factors, environmental exposures, and maternal and fetal genetic variants. Maternal periconceptional intake of folic acid containing vitamin supplements is reported to decrease the risk of CHD. The 677C-->T and 1298A-->C polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene decrease enzyme activity. OBJECTIVE: To examine the relation between CHD and maternal and fetal MTHFR polymorphisms. METHODS: 375 nuclear families were studied. The transmission/disequilibrium test was used to test for transmission distortion in complete triads. A log-linear approach was used to test for associations between CHD and maternal and offspring polymorphisms, and to estimate independently the contributions of maternal and fetal variants to relative risks. Haplotype frequencies were estimated and a haplotype transmission disequilibrium test carried out. RESULTS: The 1298C allele was transmitted less often than expected (p = 0.0013). There was no distortion in the transmission of the 677T allele, neither was there evidence of a parent of origin effect in the transmission of either of the single nucleotide polymorphisms. The 677C-1298C haplotype was also transmitted less often than expected (p = 0.0020). The relative risk associated with inheriting one copy of the 1298C allele was 0.64 (95% confidence interval, 0.48 to 0.87) and the that associated with inheriting two copies of the 1298C allele, 0.38 (0.21 to 0.70). CONCLUSIONS: The apparent protective effect of the MTHFR 1298C allele against CHD could have several explanations and further study is needed.
Authors: P W Yoon; S A Rasmussen; M C Lynberg; C A Moore; M Anderka; S L Carmichael; P Costa; C Druschel; C A Hobbs; P A Romitti; P H Langlois; L D Edmonds Journal: Public Health Rep Date: 2001 Impact factor: 2.792
Authors: Marie-Therese Doolin; Sandrine Barbaux; Maeve McDonnell; Katy Hoess; Alexander S Whitehead; Laura E Mitchell Journal: Am J Hum Genet Date: 2002-10-09 Impact factor: 11.025
Authors: Henrik Zetterberg; Björn Regland; Mona Palmér; Anne Ricksten; Lars Palmqvist; Lars Rymo; Demetrios A Arvanitis; Demetrios A Spandidos; Kaj Blennow Journal: Eur J Hum Genet Date: 2002-02 Impact factor: 4.246
Authors: Angelika de Bree; W M Monique Verschuren; Anne-Lise Bjørke-Monsen; Nathalie M J van der Put; Sandra G Heil; Frans J M Trijbels; Henk J Blom Journal: Am J Clin Nutr Date: 2003-03 Impact factor: 7.045
Authors: Mario A Cleves; Charlotte A Hobbs; Weizhi Zhao; Patrycja A Krakowiak; Stewart L MacLeod Journal: Paediatr Perinat Epidemiol Date: 2011-01-04 Impact factor: 3.980
Authors: Xinyu Tang; Mario A Cleves; Todd G Nick; Ming Li; Stewart L MacLeod; Stephen W Erickson; Jingyun Li; Gary M Shaw; Bridget S Mosley; Charlotte A Hobbs Journal: Am J Med Genet A Date: 2015-04-02 Impact factor: 2.802
Authors: Lora J H Bean; Emily G Allen; Stuart W Tinker; Natasha D Hollis; Adam E Locke; Charlotte Druschel; Charlotte A Hobbs; Leslie O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Kenneth J Dooley; Sallie B Freeman; Stephanie L Sherman Journal: Birth Defects Res A Clin Mol Teratol Date: 2011-08-24
Authors: Lourdes García-Fragoso; Inés García-García; Gloria Leavitt; Jessicca Renta; Miguel A Ayala; Carmen L Cadilla Journal: Int J Genet Mol Biol Date: 2010-03-01
Authors: Laura E Mitchell; Jin Long; Jennifer Garbarini; Prasuna Paluru; Elizabeth Goldmuntz Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-01
Authors: Karen Kuehl; Christopher Loffredo; Edward J Lammer; David M Iovannisci; Gary M Shaw Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-02
Authors: Charlotte A Hobbs; Shimul Chowdhury; Mario A Cleves; Stephen Erickson; Stewart L MacLeod; Gary M Shaw; Sanjay Shete; John S Witte; Benjamin Tycko Journal: JAMA Pediatr Date: 2014-04 Impact factor: 16.193
Authors: Gary M Shaw; Wei Lu; Huiping Zhu; Wei Yang; Farren B S Briggs; Suzan L Carmichael; Lisa F Barcellos; Edward J Lammer; Richard H Finnell Journal: BMC Med Genet Date: 2009-06-03 Impact factor: 2.103